Following establishment of risk-sharing arrangements, sales volume for certain drugs has gradually increased. This is not to say that risk-sharing has been the only driving factor, but it appears to be one of several key factors.
Risk-Sharing Arrangements May Boost Fortunes Of Certain Prescription Drugs
